Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LABCORP HOLDINGS INC. Director's Dealing 2021

Feb 19, 2021

30237_dirs_2021-02-19_4a51dd22-2f71-4bd8-9970-30b1dd454cca.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2021-02-12

Reporting Person: Wilkinson Peter J (SVP, Chief Accounting Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-02-12 Common Stock M 187 Acquired 710.2194 Direct
2021-02-12 Common Stock F 62 $238.26 Disposed 648.2194 Direct
2021-02-12 Common Stock M 680 Acquired 1328.2194 Direct
2021-02-12 Common Stock F 201 $238.26 Disposed 1127.2194 Direct
2021-02-18 Common Stock M 1533 $146.59 Acquired 2660.2194 Direct
2021-02-18 Common Stock S 2317 $241.5146 Disposed 343.2194 Direct
2021-02-18 Common Stock M 633 $182.51 Acquired 976.2194 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-02-12 Restricted Stock Unit $ M 187 Disposed Common Stock (187) Direct
2021-02-12 Restricted Stock Unit $ M 680 Disposed Common Stock (680) Direct
2021-02-18 Non-qualified Stock Options $146.59 M 1533 Disposed 2029-02-11 Common Stock (1533) Direct
2021-02-18 Non-qualified Stock Options $182.51 M 633 Disposed 2030-02-03 Common Stock (633) Direct

Footnotes

F1: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F2: Stock withholding to satisfy tax withholding obligations.

F3: The price of $241.5146 per share represents a weighted average of sales prices ranging from $240.92 to $241.651 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security
holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.

F4: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 12, 2020.

F5: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

F6: Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan.

F7: The option vests in three equal annual installments beginning on the date reflected in this column.